{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T21:48:33Z","timestamp":1784238513702,"version":"3.55.0"},"reference-count":174,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T00:00:00Z","timestamp":1749340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T00:00:00Z","timestamp":1749340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002301","name":"Eesti Teadusagentuur","doi-asserted-by":"publisher","award":["#PRG712"],"award-info":[{"award-number":["#PRG712"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002301","name":"Eesti Teadusagentuur","doi-asserted-by":"publisher","award":["#PRG712"],"award-info":[{"award-number":["#PRG712"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"DOI":"10.1007\/s12016-025-09064-z","type":"journal-article","created":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T14:27:33Z","timestamp":1749392853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["B Cell Tolerance and Obstetric Antiphospholipid Syndrome"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7721-7175","authenticated-orcid":false,"given":"Brita","family":"Laht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2483-3878","authenticated-orcid":false,"given":"Suraj","family":"Timilsina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5245-2680","authenticated-orcid":false,"given":"M. Eric","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2298-1300","authenticated-orcid":false,"given":"Raivo","family":"Uibo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,8]]},"reference":[{"key":"9064_CR1","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1016\/j.immuni.2023.10.008","volume":"56","author":"JP Hoffmann","year":"2023","unstructured":"Hoffmann JP, Liu JA, Seddu K, Klein SL (2023) Sex hormone signaling and regulation of immune function. Immunity 56:2472\u20132491. https:\/\/doi.org\/10.1016\/j.immuni.2023.10.008","journal-title":"Immunity"},{"key":"9064_CR2","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL (2016) Sex differences in immune responses. Nat Rev Immunol 16:626\u2013638. https:\/\/doi.org\/10.1038\/nri.2016.90","journal-title":"Nat Rev Immunol"},{"key":"9064_CR3","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/humrep\/15.3.713","volume":"15","author":"R Raghupathy","year":"2000","unstructured":"Raghupathy R, Makhseed M, Azizieh R, Omu A, Gupta M, Farhat R (2000) Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Hum Reprod 15:713\u2013718. https:\/\/doi.org\/10.1093\/humrep\/15.3.713","journal-title":"Hum Reprod"},{"key":"9064_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/14767050500072722","volume":"17","author":"K Richani","year":"2005","unstructured":"Richani K, Soto E, Romero R, Espinoza J, Chaiworapongsa T, Nien JK et al (2005) Normal pregnancy is characterized by systemic activation of the complement system. J Matern-Fetal Neonatal Med 17:239\u2013245. https:\/\/doi.org\/10.1080\/14767050500072722","journal-title":"J Matern-Fetal Neonatal Med"},{"key":"9064_CR5","doi-asserted-by":"publisher","unstructured":"Reichhardt MP, Lundin K, Lokki AI, Recher G, Vuoristo S, Katayama S et al (2019) Complement in Human Pre-implantation Embryos: Attack and Defense. Front Immunol 10. https:\/\/doi.org\/10.3389\/fimmu.2019.02234","DOI":"10.3389\/fimmu.2019.02234"},{"key":"9064_CR6","doi-asserted-by":"publisher","unstructured":"Girardi G, Lingo JJ, Fleming SD, Regal JF (2020) Essential Role of Complement in Pregnancy: From Implantation to Parturition and Beyond. Front Immunol 11. https:\/\/doi.org\/10.3389\/fimmu.2020.01681","DOI":"10.3389\/fimmu.2020.01681"},{"key":"9064_CR7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41584-018-0032-6","volume":"14","author":"PL Meroni","year":"2018","unstructured":"Meroni PL, Borghi MO, Grossi C, Chighizola CB, Durigutto P, Tedesco F (2018) Obstetric and vascular antiphospholipid syndrome: same antibodies but different diseases? Nat Rev Rheumatol 14:433\u2013440. https:\/\/doi.org\/10.1038\/s41584-018-0032-6","journal-title":"Nat Rev Rheumatol"},{"key":"9064_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/cei.12001","volume":"171","author":"TG Nguyen","year":"2013","unstructured":"Nguyen TG, Ward CM, Morris JM (2013) To B or not to B cells-mediate a healthy start to life. Clin Exp Immunol 171:124\u2013134. https:\/\/doi.org\/10.1111\/cei.12001","journal-title":"Clin Exp Immunol"},{"key":"9064_CR9","doi-asserted-by":"publisher","unstructured":"Valeff NJ, Ventimiglia MS, Diao L, Jensen F (2023) Lupus and recurrent pregnancy loss: the role of female sex hormones and B cells. Front Endocrinol 14. https:\/\/doi.org\/10.3389\/fendo.2023.1233883","DOI":"10.3389\/fendo.2023.1233883"},{"key":"9064_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1084\/jem.20080521","volume":"206","author":"S Pauklin","year":"2009","unstructured":"Pauklin S, Sern\u00e1ndez IV, Bachmann G, Ramiro AR, Petersen-Mahrt SK (2009) Estrogen directly activates AID transcription and function. J Exp Med 206:99\u2013111. https:\/\/doi.org\/10.1084\/jem.20080521","journal-title":"J Exp Med"},{"key":"9064_CR11","doi-asserted-by":"publisher","first-page":"37797","DOI":"10.1074\/jbc.M110.169086","volume":"285","author":"T Mai","year":"2010","unstructured":"Mai T, Zan H, Zhang J, Hawkins JS, Xu Z, Casali P (2010) Estrogen Receptors Bind to and Activate the HOXC4\/HoxC4 Promoter to Potentiate HoxC4-mediated Activation-induced Cytosine Deaminase Induction, Immunoglobulin Class Switch DNA Recombination, and Somatic Hypermutation*. J Biol Chem 285:37797\u201337810. https:\/\/doi.org\/10.1074\/jbc.M110.169086","journal-title":"J Biol Chem"},{"key":"9064_CR12","doi-asserted-by":"publisher","unstructured":"Santana-S\u00e1nchez P, Vaquero-Garc\u00eda R, Legorreta-Haquet MV, Ch\u00e1vez-S\u00e1nchez L, Ch\u00e1vez-Rueda AK (2024) Hormones and B-cell development in health and autoimmunity. Front Immunol 15. https:\/\/doi.org\/10.3389\/fimmu.2024.1385501","DOI":"10.3389\/fimmu.2024.1385501"},{"key":"9064_CR13","first-page":"123","volume":"7","author":"L Zhang","year":"2013","unstructured":"Zhang L, Chang K-K, Li M-Q, Li D-J, Yao X-Y (2013) Mouse endometrial stromal cells and progesterone inhibit the activation and regulate the differentiation and antibody secretion of mouse B cells. Int J Clin Exp Pathol 7:123\u2013133","journal-title":"Int J Clin Exp Pathol"},{"key":"9064_CR14","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s10528-016-9752-y","volume":"54","author":"MN Drehmer","year":"2016","unstructured":"Drehmer MN, Suterio DG, Muniz YCN, de Souza IR, L\u00f6fgren SE (2016) BAFF Expression is Modulated by Female Hormones in Human Immune Cells. Biochem Genet 54:722\u2013730. https:\/\/doi.org\/10.1007\/s10528-016-9752-y","journal-title":"Biochem Genet"},{"key":"9064_CR15","doi-asserted-by":"publisher","first-page":"102798","DOI":"10.1016\/j.autrev.2021.102798","volume":"20","author":"Y Dieudonn\u00e9","year":"2021","unstructured":"Dieudonn\u00e9 Y, Guffroy A, Poindron V, Sprauel PS, Martin T, Korganow A-S et al (2021) B cells in primary antiphospholipid syndrome: Review and remaining challenges. Autoimmun Rev 20:102798. https:\/\/doi.org\/10.1016\/j.autrev.2021.102798","journal-title":"Autoimmun Rev"},{"key":"9064_CR16","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3390\/ijms19020589","volume":"19","author":"L Alvarez-Rodriguez","year":"2018","unstructured":"Alvarez-Rodriguez L, Riancho-Zarrabeitia L, Calvo-Al\u00e9n J, L\u00f3pez-Hoyos M, Mart\u00ednez-Taboada V (2018) Peripheral B-Cell Subset Distribution in Primary Antiphospholipid Syndrome. Int J Mol Sci 19:589. https:\/\/doi.org\/10.3390\/ijms19020589","journal-title":"Int J Mol Sci"},{"key":"9064_CR17","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.3899\/jrheum.081079","volume":"36","author":"J Carbone","year":"2009","unstructured":"Carbone J, Gallego A, Lanio N, Navarro J, Orera M, Aguaron A et al (2009) Quantitative Abnormalities of Peripheral Blood Distinct T, B, and Natural Killer Cell Subsets and Clinical Findings in Obstetric Antiphospholipid Syndrome. J Rheumatol 36:1217\u20131225. https:\/\/doi.org\/10.3899\/jrheum.081079","journal-title":"J Rheumatol"},{"key":"9064_CR18","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1097\/CM9.0000000000000948","volume":"133","author":"X-Y Li","year":"2020","unstructured":"Li X-Y, Duan H-J, Liu X-Y, Deng X-L (2020) Change of serum B-cell activating factor level in patients with positive antiphospholipid antibodies and previous adverse pregnancy outcomes and its significance. Chin Med J (Engl) 133:2287\u20132294. https:\/\/doi.org\/10.1097\/CM9.0000000000000948","journal-title":"Chin Med J (Engl)"},{"key":"9064_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1021\/acs.jproteome.3c00554","volume":"23","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Jin S, Tian W, Shi D, Chen Y, Cui L et al (2024) Proteomics of Serum Samples for the Exploration of the Pathological Mechanism of Obstetric Antiphospholipid Syndrome. J Proteome Res 23:289\u2013300. https:\/\/doi.org\/10.1021\/acs.jproteome.3c00554","journal-title":"J Proteome Res"},{"key":"9064_CR20","doi-asserted-by":"publisher","first-page":"9921","DOI":"10.1038\/s41467-024-54228-8","volume":"15","author":"Y Dieudonn\u00e9","year":"2024","unstructured":"Dieudonn\u00e9 Y, Lorenzetti R, Rottura J, Janowska I, Frenger Q, Jacquel L et al (2024) Defective germinal center selection results in persistence of self-reactive B cells from the primary to the secondary repertoire in Primary Antiphospholipid Syndrome. Nat Commun 15:9921. https:\/\/doi.org\/10.1038\/s41467-024-54228-8","journal-title":"Nat Commun"},{"key":"9064_CR21","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1136\/ard-2023-224609","volume":"82","author":"M Barbhaiya","year":"2023","unstructured":"Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo M-C et al (2023) 2023 ACR\/EULAR antiphospholipid syndrome classification criteria. Ann Rheum Dis 82:1258\u20131270. https:\/\/doi.org\/10.1136\/ard-2023-224609","journal-title":"Ann Rheum Dis"},{"key":"9064_CR22","doi-asserted-by":"publisher","first-page":"J287","DOI":"10.1016\/j.jaut.2009.11.015","volume":"34","author":"AT Borchers","year":"2010","unstructured":"Borchers AT, Naguwa SM, Keen CL, Gershwin ME (2010) The implications of autoimmunity and pregnancy. J Autoimmun 34:J287\u2013J299. https:\/\/doi.org\/10.1016\/j.jaut.2009.11.015","journal-title":"J Autoimmun"},{"key":"9064_CR23","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.autrev.2015.01.008","volume":"14","author":"CA Viall","year":"2015","unstructured":"Viall CA, Chamley LW (2015) Histopathology in the placentae of women with antiphospholipid antibodies: A systematic review of the literature. Autoimmun Rev 14:446\u2013471. https:\/\/doi.org\/10.1016\/j.autrev.2015.01.008","journal-title":"Autoimmun Rev"},{"key":"9064_CR24","doi-asserted-by":"publisher","first-page":"SI64","DOI":"10.1093\/rheumatology\/kead632","volume":"63","author":"B de Laat","year":"2024","unstructured":"de Laat B, Gehlen R, de Groot PG (2024) Viewpoint: The value of non-criteria antiphospholipid antibodies. Rheumatology 63:SI64-71. https:\/\/doi.org\/10.1093\/rheumatology\/kead632","journal-title":"Rheumatology"},{"key":"9064_CR25","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3390\/jcm14041299","volume":"14","author":"S Be\u00e7a","year":"2025","unstructured":"Be\u00e7a S, Borrell M, Cervera R, Figueras F, Nadal A, Espinosa G et al (2025) Non-Criteria Obstetric Antiphospholipid Syndrome: Myth or Reality? J Clin Med 14:1299. https:\/\/doi.org\/10.3390\/jcm14041299","journal-title":"J Clin Med"},{"key":"9064_CR26","doi-asserted-by":"publisher","unstructured":"Liu H, Han J, Gao R, Hu Z, Tang Y, Qin L (2024) Clinical Features Between Primary Obstetric Antiphospholipid Syndrome and Non-Criteria Obstetric Antiphospholipid Syndrome and Risk Factors of Adverse Pregnancy Outcomes: A Retrospective Study of 1006 Cases. Am J Reprod Immunol 92. https:\/\/doi.org\/10.1111\/aji.13931","DOI":"10.1111\/aji.13931"},{"key":"9064_CR27","doi-asserted-by":"publisher","first-page":"8380214","DOI":"10.1155\/2019\/8380214","volume":"2019","author":"D Wang","year":"2019","unstructured":"Wang D, Lv W, Zhang S, Zhang J (2019) Advances in the Research on Anticardiolipin Antibody. J Immunol Res 2019:8380214. https:\/\/doi.org\/10.1155\/2019\/8380214","journal-title":"J Immunol Res"},{"key":"9064_CR28","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1055\/a-1701-2809","volume":"122","author":"D Green","year":"2022","unstructured":"Green D (2022) Pathophysiology of Antiphospholipid Syndrome. Thromb Haemost 122:1085\u20131095. https:\/\/doi.org\/10.1055\/a-1701-2809","journal-title":"Thromb Haemost"},{"key":"9064_CR29","doi-asserted-by":"publisher","first-page":"103101","DOI":"10.1016\/j.autrev.2022.103101","volume":"21","author":"M Jarne-Borr\u00e0s","year":"2022","unstructured":"Jarne-Borr\u00e0s M, Mir\u00f3-Mur F, Anunciaci\u00f3n-Llunell A, Alijotas-Reig J (2022) Antiphospholipid antibodies in women with recurrent embryo implantation failure: A systematic review and meta-analysis. Autoimmun Rev 21:103101. https:\/\/doi.org\/10.1016\/j.autrev.2022.103101","journal-title":"Autoimmun Rev"},{"key":"9064_CR30","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.40930","volume":"71","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader KH, Daikh DI, Brinks R, Mosca M, Ramsey-Goldman R et al (2019) 2019 EULAR\/ACR Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol Hoboken NJ 71:1400\u20131412. https:\/\/doi.org\/10.1002\/art.40930","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"9064_CR31","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1177\/0961203316640912","volume":"25","author":"N Abdel-Wahab","year":"2016","unstructured":"Abdel-Wahab N, Lopez-Olivo MA, Pinto-Patarroyo GP, Suarez-Almazor ME (2016) Systematic Review of Case Reports of Antiphospholipid Syndrome Following Infection. Lupus 25:1520\u20131531. https:\/\/doi.org\/10.1177\/0961203316640912","journal-title":"Lupus"},{"key":"9064_CR32","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1177\/0961203312438116","volume":"21","author":"P Meroni","year":"2012","unstructured":"Meroni P, Raschi E, Grossi C, Pregnolato F, Trespidi L, Acaia B et al (2012) Obstetric and vascular APS: Same autoantibodies but different diseases? Lupus 21:708\u2013710. https:\/\/doi.org\/10.1177\/0961203312438116","journal-title":"Lupus"},{"key":"9064_CR33","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/humupd\/dmi008","volume":"11","author":"A Bouman","year":"2005","unstructured":"Bouman A, Heineman MJ, Faas MM (2005) Sex hormones and the immune response in humans. Hum Reprod Update 11:411\u2013423. https:\/\/doi.org\/10.1093\/humupd\/dmi008","journal-title":"Hum Reprod Update"},{"key":"9064_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/jcm12010018","volume":"12","author":"LL van den Hoogen","year":"2023","unstructured":"van den Hoogen LL, Bisoendial RJ (2023) B-Cells and BAFF in Primary Antiphospholipid Syndrome, Targets for Therapy? J Clin Med 12:18. https:\/\/doi.org\/10.3390\/jcm12010018","journal-title":"J Clin Med"},{"key":"9064_CR35","doi-asserted-by":"publisher","unstructured":"Yun Z, Duan L, Liu X, Cai Q, Li C (2023) An update on the biologics for the treatment of antiphospholipid syndrome. Front Immunol 14. https:\/\/doi.org\/10.3389\/fimmu.2023.1145145","DOI":"10.3389\/fimmu.2023.1145145"},{"key":"9064_CR36","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1073\/pnas.87.11.4120","volume":"87","author":"HP McNeil","year":"1990","unstructured":"McNeil HP, Simpson RJ, Chesterman CN, Krilis SA (1990) Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci 87:4120\u20134124. https:\/\/doi.org\/10.1073\/pnas.87.11.4120","journal-title":"Proc Natl Acad Sci"},{"key":"9064_CR37","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1016\/0140-6736(90)91374-J","volume":"335","author":"M Galli","year":"1990","unstructured":"Galli M, Barbui T, Comfurius P, Maassen C, Hemker HC, Zwaal RFA et al (1990) Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. The Lancet 335:1544\u20131547. https:\/\/doi.org\/10.1016\/0140-6736(90)91374-J","journal-title":"The Lancet"},{"key":"9064_CR38","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S0140-6736(05)60080-3","volume":"352","author":"L Chamley","year":"1998","unstructured":"Chamley L, Duncalf A, Mitchell M, Johnson P (1998) Action of anticardiolipin and antibodies to \u03b22-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death. Lancet 352:1037\u20131038. https:\/\/doi.org\/10.1016\/S0140-6736(05)60080-3","journal-title":"Lancet"},{"key":"9064_CR39","doi-asserted-by":"publisher","first-page":"13833","DOI":"10.1021\/bi960657q","volume":"35","author":"GM Willems","year":"1996","unstructured":"Willems GM, Janssen MP, Pelsers MMAL, Comfurius P, Galli M, Zwaal RFA et al (1996) Role of divalency in the high-affinity binding of anticardiolipin antibody-\u03b22-glycoprotein I complexes to lipid membranes. Biochemistry 35:13833\u201313842. https:\/\/doi.org\/10.1021\/bi960657q","journal-title":"Biochemistry"},{"key":"9064_CR40","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jim.2005.03.016","volume":"300","author":"AD d\u2019Angeac","year":"2005","unstructured":"d\u2019Angeac AD, Stefas I, Duperray C, Rucheton M, Graafland H, Montero J-L et al (2005) Oxidation and biotinylation of beta 2 glycoprotein I glycan chains induce an increase in its affinity for anionic phospholipids similar to that obtained by the addition of anti-beta 2 glycoprotein I or anti-cardiolipin antibodies. J Immunol Methods 300:160\u2013178. https:\/\/doi.org\/10.1016\/j.jim.2005.03.016","journal-title":"J Immunol Methods"},{"key":"9064_CR41","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1182\/blood-2011-02-339564","volume":"118","author":"K Gropp","year":"2011","unstructured":"Gropp K, Weber N, Reuter M, Micklisch S, Kopka I, Hallstr\u00f6m T et al (2011) \u03b22-glycoprotein I, the major target in antiphospholipid syndrome, is a special human complement regulator. Blood 118:2774\u20132783. https:\/\/doi.org\/10.1182\/blood-2011-02-339564","journal-title":"Blood"},{"key":"9064_CR42","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0021-9150(87)90110-9","volume":"63","author":"J Nimpf","year":"1987","unstructured":"Nimpf J, Wurm H, Kostner GM (1987) \u03b22-glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation. Atherosclerosis 63:109\u2013114. https:\/\/doi.org\/10.1016\/0021-9150(87)90110-9","journal-title":"Atherosclerosis"},{"key":"9064_CR43","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/0304-4165(86)90237-0","volume":"884","author":"J Nimpf","year":"1986","unstructured":"Nimpf J, Bevers EM, Bomans PHH, Till U, Wurm H, Kostner GM et al (1986) Prothrombinase activity of human platelets is inhibited by \u03b22-glycoprotein-I. Biochim Biophys Acta BBA - Gen Subj 884:142\u2013149. https:\/\/doi.org\/10.1016\/0304-4165(86)90237-0","journal-title":"Biochim Biophys Acta BBA - Gen Subj"},{"key":"9064_CR44","doi-asserted-by":"publisher","first-page":"31113","DOI":"10.1074\/jbc.272.49.31113","volume":"272","author":"K Balasubramanian","year":"1997","unstructured":"Balasubramanian K, Chandra J, Schroit AJ (1997) Immune clearance of phosphatidylserine-expressing cells by phagocytes: The role of \u03b22-glycoprotein I in macrophage recognition. J Biol Chem 272:31113\u201331117. https:\/\/doi.org\/10.1074\/jbc.272.49.31113","journal-title":"J Biol Chem"},{"key":"9064_CR45","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/S0015-0282(00)00533-1","volume":"73","author":"N Di Simone","year":"2000","unstructured":"Di Simone N, Caliandro D, Castellani R, Ferrazzani S, Caruso A (2000) Interleukin-3 and human trophoblast: in vitro explanations for the effect of interleukin in patients with antiphospholipid antibody syndrome. Fertil Steril 73:1194\u20131200. https:\/\/doi.org\/10.1016\/S0015-0282(00)00533-1","journal-title":"Fertil Steril"},{"key":"9064_CR46","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1046\/j.1365-2249.1999.00770.x","volume":"115","author":"B Caronti","year":"1999","unstructured":"Caronti B, Calderaro C, Alessandri C, Conti F, Tinghino R, Palladini G et al (1999) \u03b22-Glycoprotein I (\u03b22-GPI) mRNA is expressed by several cell types involved in anti-phospholipid syndrome-related tissue damage. Clin Exp Immunol 115:214\u2013219. https:\/\/doi.org\/10.1046\/j.1365-2249.1999.00770.x","journal-title":"Clin Exp Immunol"},{"key":"9064_CR47","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/jb\/mvv093","volume":"158","author":"N Arase","year":"2015","unstructured":"Arase N, Arase H (2015) Cellular misfolded proteins rescued from degradation by MHC class II molecules are possible targets for autoimmune diseases. J Biochem (Tokyo) 158:367\u2013372. https:\/\/doi.org\/10.1093\/jb\/mvv093","journal-title":"J Biochem (Tokyo)"},{"key":"9064_CR48","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1182\/blood-2009-12-260976","volume":"116","author":"\u00c7 A\u011far","year":"2010","unstructured":"A\u011far \u00c7, van Os GMA, M\u00f6rgelin M, Sprenger RR, Marquart JA, Urbanus RT et al (2010) \u03b22-Glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome. Blood 116:1336\u20131343. https:\/\/doi.org\/10.1182\/blood-2009-12-260976","journal-title":"Blood"},{"key":"9064_CR49","doi-asserted-by":"publisher","first-page":"6228","DOI":"10.1093\/emboj\/18.22.6228","volume":"18","author":"R Schwarzenbacher","year":"1999","unstructured":"Schwarzenbacher R, Zeth K, Diederichs K, Gries A, Kostner GM, Laggner P et al (1999) Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome. EMBO J 18:6228\u20136239. https:\/\/doi.org\/10.1093\/emboj\/18.22.6228","journal-title":"EMBO J"},{"key":"9064_CR50","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jprot.2009.08.007","volume":"73","author":"A Kondo","year":"2009","unstructured":"Kondo A, Miyamoto T, Yonekawa O, Giessing AM, \u00d8sterlund EC, Jensen ON (2009) Glycopeptide profiling of beta-2-glycoprotein I by mass spectrometry reveals attenuated sialylation in patients with antiphospholipid syndrome. J Proteomics 73:123\u2013133. https:\/\/doi.org\/10.1016\/j.jprot.2009.08.007","journal-title":"J Proteomics"},{"key":"9064_CR51","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/art.24262","volume":"60","author":"C Bu","year":"2009","unstructured":"Bu C, Gao L, Xie W, Zhang J, He Y, Cai G et al (2009) \u03b22-glycoprotein i is a cofactor for tissue plasminogen activator\u2013mediated plasminogen activation. Arthritis Rheum 60:559\u2013568. https:\/\/doi.org\/10.1002\/art.24262","journal-title":"Arthritis Rheum"},{"key":"9064_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2019.100610","volume":"39","author":"T McDonnell","year":"2020","unstructured":"McDonnell T, Wincup C, Buchholz I, Pericleous C, Giles I, Ripoll V et al (2020) The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS. Blood Rev 39:100610. https:\/\/doi.org\/10.1016\/j.blre.2019.100610","journal-title":"Blood Rev"},{"key":"9064_CR53","doi-asserted-by":"publisher","unstructured":"Liu J-C, Zeng Q, Duan Y-G, Yeung WSB, Li RHW, Ng EHY et al (2024) B cells: roles in physiology and pathology of pregnancy. Front Immunol 15. https:\/\/doi.org\/10.3389\/fimmu.2024.1456171","DOI":"10.3389\/fimmu.2024.1456171"},{"key":"9064_CR54","doi-asserted-by":"publisher","first-page":"873493","DOI":"10.3389\/fimmu.2022.873493","volume":"13","author":"NJ Valeff","year":"2022","unstructured":"Valeff NJ, Ventimiglia MS, Dibo M, Markert UR, Jensen F (2022) Splenic B1 B Cells Acquire a Proliferative and Anti-Inflamatory Profile During Pregnancy in Mice. Front Immunol 13:873493. https:\/\/doi.org\/10.3389\/fimmu.2022.873493","journal-title":"Front Immunol"},{"key":"9064_CR55","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1111\/jth.14427","volume":"17","author":"R Hisada","year":"2019","unstructured":"Hisada R, Kato M, Sugawara E, Kanda M, Fujieda Y, Oku K et al (2019) Circulating plasmablasts contribute to antiphospholipid antibody production, associated with type I interferon upregulation. J Thromb Haemost 17:1134\u20131143. https:\/\/doi.org\/10.1111\/jth.14427","journal-title":"J Thromb Haemost"},{"key":"9064_CR56","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1600-0897.1996.tb00002.x","volume":"35","author":"MH Lachapelle","year":"1996","unstructured":"Lachapelle MH, Miron P, Hemmings R, Baron C, Roy DC (1996) Flow-Cytometric Characterization of Hematopoietic Cells in Non-Pregnant Human Endometrium. Am J Reprod Immunol 35:5\u201313. https:\/\/doi.org\/10.1111\/j.1600-0897.1996.tb00002.x","journal-title":"Am J Reprod Immunol"},{"key":"9064_CR57","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1038\/s41598-017-03191-0","volume":"7","author":"D Feyaerts","year":"2017","unstructured":"Feyaerts D, Benner M, van Cranenbroek B, van der Heijden OWH, Joosten I, van der Molen RG (2017) Human uterine lymphocytes acquire a more experienced and tolerogenic phenotype during pregnancy. Sci Rep 7:2884. https:\/\/doi.org\/10.1038\/s41598-017-03191-0","journal-title":"Sci Rep"},{"key":"9064_CR58","doi-asserted-by":"publisher","first-page":"709280","DOI":"10.3389\/fcell.2021.709280","volume":"9","author":"M Shen","year":"2021","unstructured":"Shen M, Child T, Mittal M, Sarodey G, Salim R, Granne I et al (2021) B Cell Subset Analysis and Gene Expression Characterization in Mid-Luteal Endometrium. Front Cell Dev Biol 9:709280. https:\/\/doi.org\/10.3389\/fcell.2021.709280","journal-title":"Front Cell Dev Biol"},{"key":"9064_CR59","doi-asserted-by":"publisher","first-page":"108204","DOI":"10.1016\/j.celrep.2020.108204","volume":"32","author":"M Benner","year":"2020","unstructured":"Benner M, Feyaerts D, Garc\u00eda CC, Inci N, L\u00f3pez SC, Fasse E et al (2020) Clusters of Tolerogenic B Cells Feature in the Dynamic Immunological Landscape of the Pregnant Uterus. Cell Rep 32:108204. https:\/\/doi.org\/10.1016\/j.celrep.2020.108204","journal-title":"Cell Rep"},{"key":"9064_CR60","doi-asserted-by":"publisher","unstructured":"Guzman-Genuino RM, Eldi P, Garcia-Valtanen P, Hayball JD, Diener KR (2019) Uterine B Cells Exhibit Regulatory Properties During the Peri-Implantation Stage of Murine Pregnancy. Front Immunol 10. https:\/\/doi.org\/10.3389\/fimmu.2019.02899","DOI":"10.3389\/fimmu.2019.02899"},{"key":"9064_CR61","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/jlb.61.4.427","volume":"61","author":"GR Yeaman","year":"1997","unstructured":"Yeaman GR, Guyre PM, Fanger MW, Collins JE, White HD, Rathbun W et al (1997) Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. J Leukoc Biol 61:427\u2013435. https:\/\/doi.org\/10.1002\/jlb.61.4.427","journal-title":"J Leukoc Biol"},{"key":"9064_CR62","doi-asserted-by":"publisher","first-page":"15200","DOI":"10.3390\/ijms232315200","volume":"23","author":"M \u00c2ngelo-Dias","year":"2022","unstructured":"\u00c2ngelo-Dias M, Martins C, Dias SS, Borrego LM, Lima J (2022) Association of B Cells with Idiopathic Recurrent Pregnancy Loss: A Systematic Review and Meta-Analysis. Int J Mol Sci 23:15200. https:\/\/doi.org\/10.3390\/ijms232315200","journal-title":"Int J Mol Sci"},{"key":"9064_CR63","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3390\/jcm11030675","volume":"11","author":"J Alijotas-Reig","year":"2022","unstructured":"Alijotas-Reig J, Esteve-Valverde E, Anunciaci\u00f3n-Llunell A, Marques-Soares J, Pardos-Gea J, Mir\u00f3-Mur F (2022) Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review. J Clin Med 11:675. https:\/\/doi.org\/10.3390\/jcm11030675","journal-title":"J Clin Med"},{"key":"9064_CR64","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/nri3795","volume":"15","author":"SL Nutt","year":"2015","unstructured":"Nutt SL, Hodgkin PD, Tarlinton DM, Corcoran LM (2015) The generation of antibody-secreting plasma cells. Nat Rev Immunol 15:160\u2013171. https:\/\/doi.org\/10.1038\/nri3795","journal-title":"Nat Rev Immunol"},{"key":"9064_CR65","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12967-020-02289-w","volume":"18","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Zhang Y, Han J, Yang M, Zhu J, Jin T (2020) Transitional B cells involved in autoimmunity and their impact on neuroimmunological diseases. J Transl Med 18:131. https:\/\/doi.org\/10.1186\/s12967-020-02289-w","journal-title":"J Transl Med"},{"key":"9064_CR66","doi-asserted-by":"publisher","unstructured":"Gan Y, Zhong X, Zhao Y, Li G, Ye H, Li C (2022) Low dose versus standard dose rituximab for the treatment of antiphospholipid syndrome: A pilot study from a tertiary medical center. Front Immunol 13. https:\/\/doi.org\/10.3389\/fimmu.2022.971366.","DOI":"10.3389\/fimmu.2022.971366"},{"key":"9064_CR67","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.autrev.2013.05.004","volume":"12","author":"H Berman","year":"2013","unstructured":"Berman H, Rodr\u00edguez-Pint\u00f3 I, Cervera R, Morel N, Costedoat-Chalumeau N, Erkan D et al (2013) Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab. Autoimmun Rev 12:1085\u20131090. https:\/\/doi.org\/10.1016\/j.autrev.2013.05.004","journal-title":"Autoimmun Rev"},{"key":"9064_CR68","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1182\/blood-2014-08-593624","volume":"125","author":"K Tanimura","year":"2015","unstructured":"Tanimura K, Jin H, Suenaga T, Morikami S, Arase N, Kishida K et al (2015) \u03b22-Glycoprotein I\/HLA class II complexes are novel autoantigens in antiphospholipid syndrome. Blood 125:2835\u20132844. https:\/\/doi.org\/10.1182\/blood-2014-08-593624","journal-title":"Blood"},{"key":"9064_CR69","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3109\/08916939209001909","volume":"13","author":"K Hartung","year":"1992","unstructured":"Hartung K, Coldewey R, Corvetta A, Deicher H, Kalden JR, Krapf F et al (1992) Mhc Gene Products and Anticardiolipin Antibodies in Systemic Lupus Erythematosus Results of a Multicenter Study. Autoimmunity 13:95\u201399. https:\/\/doi.org\/10.3109\/08916939209001909","journal-title":"Autoimmunity"},{"key":"9064_CR70","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/s1568-9972(03)00068-5","volume":"2","author":"G Domenico Sebastiani","year":"2003","unstructured":"Domenico Sebastiani G, Minisola G, Galeazzi M (2003) HLA class II alleles and genetic predisposition to the antiphospholipid syndrome. Autoimmun Rev 2:387\u2013394. https:\/\/doi.org\/10.1016\/s1568-9972(03)00068-5","journal-title":"Autoimmun Rev"},{"key":"9064_CR71","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jri.2018.07.003","volume":"129","author":"KB Ziegler","year":"2018","unstructured":"Ziegler KB, Muzzio DO, Matzner F, Bommer I, Ventimiglia MS, Malinowsky K et al (2018) Human pregnancy is accompanied by modifications in B cell development and immunoglobulin profile. J Reprod Immunol 129:40\u201347. https:\/\/doi.org\/10.1016\/j.jri.2018.07.003","journal-title":"J Reprod Immunol"},{"key":"9064_CR72","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10238-021-00720-0","volume":"22","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Lin M, Hao X, Ping M, Zhang H, Zheng J (2022) Imbalance of circulating CTLA4+ follicular helper and follicular regulatory T cells in obstetric antiphospholipid syndrome. Clin Exp Med 22:27\u201336. https:\/\/doi.org\/10.1007\/s10238-021-00720-0","journal-title":"Clin Exp Med"},{"key":"9064_CR73","first-page":"425","volume":"45","author":"MA Mohamad","year":"2023","unstructured":"Mohamad MA, Ahmad Asnawi AW, Suhiman MS, Sathar J, Hayati AR, Abdul Rahim NS et al (2023) Placenta microRNA profile of patient with Obstetric Antiphospholipid Syndrome. Malays J Pathol 45:425\u2013440","journal-title":"Malays J Pathol"},{"key":"9064_CR74","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/ard-2023-224930","volume":"83","author":"C Lu","year":"2024","unstructured":"Lu C, Gao R, Qing P, Zeng X, Liao X, Cheng M et al (2024) Single-cell transcriptome analyses reveal disturbed decidual homoeostasis in obstetric antiphospholipid syndrome. Ann Rheum Dis 83:624\u2013637. https:\/\/doi.org\/10.1136\/ard-2023-224930","journal-title":"Ann Rheum Dis"},{"key":"9064_CR75","doi-asserted-by":"publisher","unstructured":"Bacalao MA, Satterthwaite AB (2021) Recent Advances in Lupus B Cell Biology: PI3K, IFN\u03b3, and Chromatin. Front Immunol 11. https:\/\/doi.org\/10.3389\/fimmu.2020.615673.","DOI":"10.3389\/fimmu.2020.615673"},{"key":"9064_CR76","doi-asserted-by":"publisher","first-page":"e13366","DOI":"10.1111\/sji.13366","volume":"99","author":"Y Wang","year":"2024","unstructured":"Wang Y, Li S, Meng J, Yu R, Wang Q, Tian X et al (2024) Changes in serum immunoglobulin G glycosylation patterns for antiphospholipid syndrome patients with lectin microarray. Scand J Immunol 99:e13366. https:\/\/doi.org\/10.1111\/sji.13366","journal-title":"Scand J Immunol"},{"key":"9064_CR77","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/rheumatology\/keab416","volume":"61","author":"T Liu","year":"2022","unstructured":"Liu T, Han J, Zhang R, Tang Z, Yi G, Gong W et al (2022) Characteristics of purified anti-\u03b22GPI IgG N-glycosylation associate with thrombotic, obstetric and catastrophic antiphospholipid syndrome. Rheumatology 61:1243\u20131254. https:\/\/doi.org\/10.1093\/rheumatology\/keab416","journal-title":"Rheumatology"},{"key":"9064_CR78","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1006\/jaut.2000.0409","volume":"15","author":"M Petri","year":"2000","unstructured":"Petri M (2000) Epidemiology of the Antiphospholipid Antibody Syndrome. J Autoimmun 15:145\u2013151. https:\/\/doi.org\/10.1006\/jaut.2000.0409","journal-title":"J Autoimmun"},{"key":"9064_CR79","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1002\/acr.22066","volume":"65","author":"L Andreoli","year":"2013","unstructured":"Andreoli L, Chighizola CB, Banzato A, Pons-Estel GJ, De Jesus GR, Erkan D (2013) Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: A critical review of the literature. Arthritis Care Res 65:1869\u20131873. https:\/\/doi.org\/10.1002\/acr.22066","journal-title":"Arthritis Care Res"},{"key":"9064_CR80","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jri.2014.09.052","volume":"107","author":"ZS Bowman","year":"2015","unstructured":"Bowman ZS, W\u00fcnsche V, Porter TF, Silver RM, Branch DW (2015) Prevalence of antiphospholipid antibodies and risk of subsequent adverse obstetric outcomes in women with prior pregnancy loss. J Reprod Immunol 107:59\u201363. https:\/\/doi.org\/10.1016\/j.jri.2014.09.052","journal-title":"J Reprod Immunol"},{"key":"9064_CR81","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11926-021-01038-2","volume":"23","author":"JY Dabit","year":"2022","unstructured":"Dabit JY, Valenzuela-Almada MO, Vallejo-Ramos S, Duarte-Garc\u00eda A (2022) Epidemiology of Antiphospholipid Syndrome in the General Population. Curr Rheumatol Rep 23:85. https:\/\/doi.org\/10.1007\/s11926-021-01038-2","journal-title":"Curr Rheumatol Rep"},{"key":"9064_CR82","doi-asserted-by":"publisher","first-page":"103304","DOI":"10.1016\/j.jri.2021.103304","volume":"145","author":"A Spinillo","year":"2021","unstructured":"Spinillo A, Bellingeri C, De Maggio I, Riceputi G, Pandolfi MP, Spada C et al (2021) The impact of various entities of antiphospholipid antibodies positivity on adverse pregnancy outcome. An epidemiological perspective. J Reprod Immunol 145:103304. https:\/\/doi.org\/10.1016\/j.jri.2021.103304","journal-title":"J Reprod Immunol"},{"key":"9064_CR83","doi-asserted-by":"publisher","unstructured":"Santacruz JC, Mantilla MJ, Rueda I, Pulido S, Rodr\u00edguez G, Londono J (n.d.) Obstetric Antiphospholipid Syndrome From the Perspective of a Rheumatologist. Cureus 14:e21090. https:\/\/doi.org\/10.7759\/cureus.21090","DOI":"10.7759\/cureus.21090"},{"key":"9064_CR84","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/aji.12341","volume":"73","author":"K Poulton","year":"2015","unstructured":"Poulton K, Ripoll VM, Pericleous C, Meroni PL, Gerosa M, Ioannou Y et al (2015) Purified IgG from Patients with Obstetric but not IgG from Non-obstetric Antiphospholipid Syndrome Inhibit Trophoblast Invasion. Am J Reprod Immunol 73:390\u2013401. https:\/\/doi.org\/10.1111\/aji.12341","journal-title":"Am J Reprod Immunol"},{"key":"9064_CR85","doi-asserted-by":"publisher","first-page":"102430","DOI":"10.1016\/j.rpth.2024.102430","volume":"8","author":"AK Rhein","year":"2024","unstructured":"Rhein AK, Rabinovich A, Abuhasira R, Lubaton-Barshishat S, Erez O (2024) Obstetric antiphospholipid syndrome carries an increased lifetime risk for obstetric and thrombotic complications\u2014a population-based study. Res Pract Thromb Haemost 8:102430. https:\/\/doi.org\/10.1016\/j.rpth.2024.102430","journal-title":"Res Pract Thromb Haemost"},{"key":"9064_CR86","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/humupd\/dmu049","volume":"21","author":"M Tong","year":"2015","unstructured":"Tong M, Viall CA, Chamley LW (2015) Antiphospholipid antibodies and the placenta: a systematic review of their in vitro effects and modulation by treatment. Hum Reprod Update 21:97\u2013118. https:\/\/doi.org\/10.1093\/humupd\/dmu049","journal-title":"Hum Reprod Update"},{"key":"9064_CR87","doi-asserted-by":"publisher","first-page":"16500","DOI":"10.3390\/ijerph192416500","volume":"19","author":"O Iordache","year":"2022","unstructured":"Iordache O, Anastasiu-Popov DM, Anastasiu DM, Craina M, Dahma G, Sacarin G et al (2022) A Retrospective Assessment of Thrombophilia in Pregnant Women with First and Second Trimester Pregnancy Loss. Int J Environ Res Public Health 19:16500. https:\/\/doi.org\/10.3390\/ijerph192416500","journal-title":"Int J Environ Res Public Health"},{"key":"9064_CR88","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.phrs.2018.01.009","volume":"133","author":"G Medina","year":"2018","unstructured":"Medina G, Vera-Lastra O, Peralta-Amaro AL, Jim\u00e9nez-Arellano MP, Saavedra MA, Cruz-Dom\u00ednguez MP et al (2018) Metabolic syndrome, autoimmunity and rheumatic diseases. Pharmacol Res 133:277\u2013288. https:\/\/doi.org\/10.1016\/j.phrs.2018.01.009","journal-title":"Pharmacol Res"},{"key":"9064_CR89","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.fertnstert.2023.09.012","volume":"120","author":"JH Bae","year":"2023","unstructured":"Bae JH, Jung YM, Lee J, Shivakumar M, Park C-W, Park JS et al (2023) Future risk of metabolic syndrome after recurrent pregnancy loss: a cohort study using UK Biobank. Fertil Steril 120:1227\u20131233. https:\/\/doi.org\/10.1016\/j.fertnstert.2023.09.012","journal-title":"Fertil Steril"},{"key":"9064_CR90","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/art.39453","volume":"68","author":"V Ulrich","year":"2016","unstructured":"Ulrich V, Gelber SE, Vukelic M, Sacharidou A, Herz J, Urbanus RT et al (2016) ApoE Receptor 2 Mediation of Trophoblast Dysfunction and Pregnancy Complications Induced by Antiphospholipid Antibodies in Mice. Arthritis Rheumatol Hoboken NJ 68:730\u2013739. https:\/\/doi.org\/10.1002\/art.39453","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"9064_CR91","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1161\/CIRCRESAHA.120.318941","volume":"129","author":"H Chu","year":"2021","unstructured":"Chu H, Sacharidou A, Nguyen A, Li C, Chambliss KL, Salmon JE et al (2021) Protein Phosphatase 2A Activation Via ApoER2 in Trophoblasts Drives Preeclampsia in a Mouse Model of the Antiphospholipid Syndrome. Circ Res 129:735\u2013750. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.318941","journal-title":"Circ Res"},{"key":"9064_CR92","doi-asserted-by":"publisher","unstructured":"Di Simone N, Meroni PL, Del Papa N, Raschi E, Caliandro D, De Carolis S et al (2000) Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered \u03b22-glycoprotein I. Arthritis Rheum 43:140\u201350. https:\/\/doi.org\/10.1002\/1529-0131(200001)43:1<140::AID-ANR18>3.0.CO;2-P","DOI":"10.1002\/1529-0131(200001)43:1<140::AID-ANR18>3.0.CO;2-P"},{"key":"9064_CR93","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1095\/biolreprod.110.083410","volume":"83","author":"N Di Simone","year":"2010","unstructured":"Di Simone N, Di Nicuolo F, D\u2019Ippolito S, Castellani R, Tersigni C, Caruso A et al (2010) Antiphospholipid Antibodies Affect Human Endometrial Angiogenesis1. Biol Reprod 83:212\u2013219. https:\/\/doi.org\/10.1095\/biolreprod.110.083410","journal-title":"Biol Reprod"},{"key":"9064_CR94","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1136\/ard.2004.021444","volume":"64","author":"N Di Simone","year":"2005","unstructured":"Di Simone N, Raschi E, Testoni C, Castellani R, D\u2019Asta M, Shi T et al (2005) Pathogenic role of anti-\u03b22-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of \u03b22-glycoprotein I binding to trophoblast cells and functional effects of anti-\u03b22-glycoprotein I antibodies in vitro. Ann Rheum Dis 64:462\u2013467. https:\/\/doi.org\/10.1136\/ard.2004.021444","journal-title":"Ann Rheum Dis"},{"key":"9064_CR95","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.fertnstert.2004.07.978","volume":"83","author":"S Quenby","year":"2005","unstructured":"Quenby S, Mountfield S, Cartwright JE, Whitley GStJ, Chamley L, Vince G (2005) Antiphospholipid antibodies prevent extravillous trophoblast differentiation. Fertil Steril 83:691\u20138. https:\/\/doi.org\/10.1016\/j.fertnstert.2004.07.978","journal-title":"Fertil Steril"},{"key":"9064_CR96","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1196\/annals.1351.034","volume":"1069","author":"N Di Simone","year":"2006","unstructured":"Di Simone N, Castellani R, Raschi E, Orietta Borghi M, Meroni PL, Caruso A (2006) Anti-Beta-2 Glycoprotein I Antibodies Affect Bcl-2 and Bax Trophoblast Expression without Evidence of Apoptosis. Ann N Y Acad Sci 1069:364\u201376. https:\/\/doi.org\/10.1196\/annals.1351.034","journal-title":"Ann N Y Acad Sci"},{"key":"9064_CR97","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jri.2012.03.487","volume":"94","author":"P Pantham","year":"2012","unstructured":"Pantham P, Rosario R, Chen Q, Print CG, Chamley LW (2012) Transcriptomic analysis of placenta affected by antiphospholipid antibodies: following the TRAIL of trophoblast death. J Reprod Immunol 94:151\u2013154. https:\/\/doi.org\/10.1016\/j.jri.2012.03.487","journal-title":"J Reprod Immunol"},{"key":"9064_CR98","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/1756-185X.13468","volume":"22","author":"K-T Tang","year":"2019","unstructured":"Tang K-T, Hsieh T-Y, Chao Y-H, Li J-P, Lan J-L, Lin C-C et al (2019) Apoptosis in patients with primary antiphospholipid antibody syndrome. Int J Rheum Dis 22:677\u2013685. https:\/\/doi.org\/10.1111\/1756-185X.13468","journal-title":"Int J Rheum Dis"},{"key":"9064_CR99","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jaut.2013.08.005","volume":"47","author":"CA Viall","year":"2013","unstructured":"Viall CA, Chen Q, Liu B, Hickey A, Snowise S, Salmon JE et al (2013) Antiphospholipid antibodies internalised by human syncytiotrophoblast cause aberrant cell death and the release of necrotic trophoblast debris. J Autoimmun 47:45\u201357. https:\/\/doi.org\/10.1016\/j.jaut.2013.08.005","journal-title":"J Autoimmun"},{"key":"9064_CR100","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.1016\/j.placenta.2013.10.014","volume":"35","author":"LW Chamley","year":"2014","unstructured":"Chamley LW, Holland OJ, Chen Q, Viall CA, Stone PR, Abumaree M (2014) Review: Where is the maternofetal interface? Placenta 35:S74-80. https:\/\/doi.org\/10.1016\/j.placenta.2013.10.014","journal-title":"Placenta"},{"key":"9064_CR101","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/art.40416","volume":"70","author":"MJ Mulla","year":"2018","unstructured":"Mulla MJ, Weel IC, Potter JA, Gysler SM, Salmon JE, Pera\u00e7oli MTS et al (2018) Antiphospholipid Antibodies Inhibit Trophoblast Toll-Like Receptor and Inflammasome Negative Regulators. Arthritis Rheumatol 70:891\u2013902. https:\/\/doi.org\/10.1002\/art.40416","journal-title":"Arthritis Rheumatol"},{"key":"9064_CR102","doi-asserted-by":"publisher","first-page":"102437","DOI":"10.1016\/j.jaut.2020.102437","volume":"111","author":"R Zussman","year":"2020","unstructured":"Zussman R, Xu LY, Damani T, Groom KM, Chen Q, Seers B et al (2020) Antiphospholipid antibodies can specifically target placental mitochondria and induce ROS production. J Autoimmun 111:102437. https:\/\/doi.org\/10.1016\/j.jaut.2020.102437","journal-title":"J Autoimmun"},{"key":"9064_CR103","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jaut.2018.07.002","volume":"93","author":"VM Ripoll","year":"2018","unstructured":"Ripoll VM, Pregnolato F, Mazza S, Bodio C, Grossi C, McDonnell T et al (2018) Gene expression profiling identifies distinct molecular signatures in thrombotic and obstetric antiphospholipid syndrome. J Autoimmun 93:114\u2013123. https:\/\/doi.org\/10.1016\/j.jaut.2018.07.002","journal-title":"J Autoimmun"},{"key":"9064_CR104","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12964-020-00579-w","volume":"18","author":"H-X Tan","year":"2020","unstructured":"Tan H-X, Yang S-L, Li M-Q, Wang H-Y (2020) Autophagy suppression of trophoblast cells induces pregnancy loss by activating decidual NK cytotoxicity and inhibiting trophoblast invasion. Cell Commun Signal 18:73. https:\/\/doi.org\/10.1186\/s12964-020-00579-w","journal-title":"Cell Commun Signal"},{"key":"9064_CR105","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1080\/15548627.2019.1707494","volume":"16","author":"A Nakashima","year":"2020","unstructured":"Nakashima A, Cheng S-B, Ikawa M, Yoshimori T, Huber WJ, Menon R et al (2020) Evidence for lysosomal biogenesis proteome defect and impaired autophagy in preeclampsia. Autophagy 16:1771\u20131785. https:\/\/doi.org\/10.1080\/15548627.2019.1707494","journal-title":"Autophagy"},{"key":"9064_CR106","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1016\/j.ygeno.2021.06.016","volume":"113","author":"N Valeff","year":"2021","unstructured":"Valeff N, Muzzio DO, Matzner F, Dibo M, Golchert J, Homuth G et al (2021) B cells acquire a unique and differential transcriptomic profile during pregnancy. Genomics 113:2614\u20132622. https:\/\/doi.org\/10.1016\/j.ygeno.2021.06.016","journal-title":"Genomics"},{"key":"9064_CR107","doi-asserted-by":"publisher","first-page":"1719720","DOI":"10.1155\/2016\/1719720","volume":"2016","author":"S Cheng","year":"2016","unstructured":"Cheng S, Wang H, Zhou H (2016) The Role of TLR4 on B Cell Activation and Anti-\u03b22GPI Antibody Production in the Antiphospholipid Syndrome. J Immunol Res 2016:1719720. https:\/\/doi.org\/10.1155\/2016\/1719720","journal-title":"J Immunol Res"},{"key":"9064_CR108","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1182\/blood-2011-09-378851","volume":"120","author":"T Colasanti","year":"2012","unstructured":"Colasanti T, Alessandri C, Capozzi A, Sorice M, Delunardo F, Longo A et al (2012) Autoantibodies specific to a peptide of \u03b22-glycoprotein I cross-react with TLR4, inducing a proinflammatory phenotype in endothelial cells and monocytes. Blood 120:3360\u20133370. https:\/\/doi.org\/10.1182\/blood-2011-09-378851","journal-title":"Blood"},{"key":"9064_CR109","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1002\/art.22802","volume":"56","author":"M Sorice","year":"2007","unstructured":"Sorice M, Longo A, Capozzi A, Garofalo T, Misasi R, Alessandri C et al (2007) Anti\u2013\u03b22-glycoprotein I antibodies induce monocyte release of tumor necrosis factor \u03b1 and tissue factor by signal transduction pathways involving lipid rafts. Arthritis Rheum 56:2687\u20132697. https:\/\/doi.org\/10.1002\/art.22802","journal-title":"Arthritis Rheum"},{"key":"9064_CR110","doi-asserted-by":"publisher","first-page":"485","DOI":"10.4049\/jimmunol.174.1.485","volume":"174","author":"J Berman","year":"2005","unstructured":"Berman J, Girardi G, Salmon JE (2005) TNF-\u03b1 Is a Critical Effector and a Target for Therapy in Antiphospholipid Antibody-Induced Pregnancy Loss1. J Immunol 174:485\u2013490. https:\/\/doi.org\/10.4049\/jimmunol.174.1.485","journal-title":"J Immunol"},{"key":"9064_CR111","doi-asserted-by":"publisher","first-page":"6939","DOI":"10.1182\/blood-2010-12-325951","volume":"117","author":"\u00c7 A\u011far","year":"2011","unstructured":"A\u011far \u00c7, de Groot PG, M\u00f6rgelin M, Monk SDDC, van Os G, Levels JHM et al (2011) \u03b22-Glycoprotein I: a novel component of innate immunity. Blood 117:6939\u20136947. https:\/\/doi.org\/10.1182\/blood-2010-12-325951","journal-title":"Blood"},{"key":"9064_CR112","doi-asserted-by":"publisher","first-page":"109745","DOI":"10.1016\/j.clim.2023.109745","volume":"255","author":"C Mineo","year":"2023","unstructured":"Mineo C, Shaul PW, Bermas BL (2023) The pathogenesis of obstetric APS: a 2023 update. Clin Immunol 255:109745. https:\/\/doi.org\/10.1016\/j.clim.2023.109745","journal-title":"Clin Immunol"},{"key":"9064_CR113","doi-asserted-by":"publisher","first-page":"4570715","DOI":"10.1155\/2017\/4570715","volume":"2017","author":"V Manganelli","year":"2017","unstructured":"Manganelli V, Capozzi A, Truglia S, Alessandri C, Lococo E, Garofalo T et al (2017) Elevated Serum Level of HMGB1 in Patients with the Antiphospholipid Syndrome. J Immunol Res 2017:4570715. https:\/\/doi.org\/10.1155\/2017\/4570715","journal-title":"J Immunol Res"},{"key":"9064_CR114","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1042\/CS20191245","volume":"134","author":"Y Tang","year":"2020","unstructured":"Tang Y, Chen Y, Nursalim Y, Groom K, Hickey A, Chamley L et al (2020) Endoplasmic reticulum stress occurs in association with the extrusion of toxic extracellular vesicles from human placentae treated with antiphospholipid antibodies. Clin Sci 134:459\u2013472. https:\/\/doi.org\/10.1042\/CS20191245","journal-title":"Clin Sci"},{"issue":"62","key":"9064_CR115","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1600-0897.2009.00717.x","volume":"2009","author":"MJ Mulla","year":"1989","unstructured":"Mulla MJ, Brosens JJ, Chamley LW, Giles I, Pericleous C, Rahman A et al (1989) Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4\/MyD88 pathway. Am J Reprod Immunol N Y N 2009(62):96\u2013111. https:\/\/doi.org\/10.1111\/j.1600-0897.2009.00717.x","journal-title":"Am J Reprod Immunol N Y N"},{"key":"9064_CR116","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/molehr\/gaw027","volume":"22","author":"SM Gysler","year":"2016","unstructured":"Gysler SM, Mulla MJ, Guerra M, Brosens JJ, Salmon JE, Chamley LW et al (2016) Antiphospholipid antibody-induced miR-146a-3p drives trophoblast interleukin-8 secretion through activation of Toll-like receptor 8. Mol Hum Reprod 22:465\u2013474. https:\/\/doi.org\/10.1093\/molehr\/gaw027","journal-title":"Mol Hum Reprod"},{"key":"9064_CR117","doi-asserted-by":"publisher","first-page":"104255","DOI":"10.1016\/j.jri.2024.104255","volume":"164","author":"CS Coenen","year":"2024","unstructured":"Coenen CS, Hidalgo TN, Lynn T, Jones DM, Salmon JE, Chamley LW et al (2024) Antiphospholipid-exposed trophoblast-derived extracellular vesicles express elevated levels of TLR7\/8-activating microRNAs and induce endometrial endothelial activation, in part, through TLR7. J Reprod Immunol 164:104255. https:\/\/doi.org\/10.1016\/j.jri.2024.104255","journal-title":"J Reprod Immunol"},{"key":"9064_CR118","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1002\/art.39247","volume":"67","author":"S Yalavarthi","year":"2015","unstructured":"Yalavarthi S, Gould TJ, Rao AN, Mazza LF, Morris AE, N\u00fa\u00f1ez-\u00c1lvarez C et al (2015) Release of Neutrophil Extracellular Traps by Neutrophils Stimulated With Antiphospholipid Antibodies: A Newly Identified Mechanism of Thrombosis in the Antiphospholipid Syndrome. Arthritis Rheumatol 67:2990\u20133003. https:\/\/doi.org\/10.1002\/art.39247","journal-title":"Arthritis Rheumatol"},{"key":"9064_CR119","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.2353\/ajpath.2006.060185","volume":"169","author":"CJ Lockwood","year":"2006","unstructured":"Lockwood CJ, Arcuri F, Toti P, De Felice C, Krikun G, Guller S et al (2006) Tumor necrosis factor-\u03b1 and interleukin-1\u03b2 regulate interleukin-8 expression in third trimester decidual cells: Implications for the genesis of chorioamnionitis. Am J Pathol 169:1294\u20131302. https:\/\/doi.org\/10.2353\/ajpath.2006.060185","journal-title":"Am J Pathol"},{"key":"9064_CR120","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.placenta.2024.05.136","volume":"153","author":"Y Wang","year":"2024","unstructured":"Wang Y, Lv Q, Li J, Hu M, Li H, Zhang M et al (2024) The protective mechanism of human umbilical cord mesenchymal stem cell-derived exosomes against neutrophil extracellular trap-induced placental damage. Placenta 153:59\u201374. https:\/\/doi.org\/10.1016\/j.placenta.2024.05.136","journal-title":"Placenta"},{"key":"9064_CR121","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1093\/rheumatology\/kead517","volume":"63","author":"M Zen","year":"2024","unstructured":"Zen M, Tonello M, Favaro M, Del Ross T, Calligaro A, Giollo A et al (2024) Antiphospholipid antibody carriers and patients with quiescent antiphospholipid syndrome show persistent subclinical complement activation. Rheumatol U K 63:1733\u20131738. https:\/\/doi.org\/10.1093\/rheumatology\/kead517","journal-title":"Rheumatol U K"},{"key":"9064_CR122","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1084\/jem.200116116","volume":"195","author":"VM Holers","year":"2002","unstructured":"Holers VM, Girardi G, Mo L, Guthridge JM, Molina H, Pierangeli SS et al (2002) Complement C3 Activation Is Required for Antiphospholipid Antibody-induced Fetal Loss. J Exp Med 195:211\u2013220. https:\/\/doi.org\/10.1084\/jem.200116116","journal-title":"J Exp Med"},{"key":"9064_CR123","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1177\/0961203312444172","volume":"21","author":"S De Carolis","year":"2012","unstructured":"De Carolis S, Botta A, Santucci S, Salvi S, Moresi S, Di Pasquo E et al (2012) Complementemia and obstetric outcome in pregnancy with antiphospholipid syndrome. Lupus 21:776\u2013778. https:\/\/doi.org\/10.1177\/0961203312444172","journal-title":"Lupus"},{"key":"9064_CR124","doi-asserted-by":"publisher","first-page":"167.e1","DOI":"10.1016\/j.ajog.2006.10.879","volume":"196","author":"JM Shamonki","year":"2007","unstructured":"Shamonki JM, Salmon JE, Hyjek E, Baergen RN (2007) Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies. Am J Obstet Gynecol 196:167.e1-167.e5. https:\/\/doi.org\/10.1016\/j.ajog.2006.10.879","journal-title":"Am J Obstet Gynecol"},{"key":"9064_CR125","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/ki.2011.497","volume":"81","author":"D Cohen","year":"2012","unstructured":"Cohen D, Colvin RB, Daha MR, Drachenberg CB, Haas M, Nickeleit V et al (2012) Pros and cons for C4d as a biomarker. Kidney Int 81:628\u2013639. https:\/\/doi.org\/10.1038\/ki.2011.497","journal-title":"Kidney Int"},{"key":"9064_CR126","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1177\/0961203320947154","volume":"29","author":"V Bitsadze","year":"2020","unstructured":"Bitsadze V, Nalli C, Khizroeva J, Lini D, Andreoli L, Lojacono A et al (2020) APS pregnancy \u2013 The offspring. Lupus 29:1336\u20131345. https:\/\/doi.org\/10.1177\/0961203320947154","journal-title":"Lupus"},{"key":"9064_CR127","doi-asserted-by":"publisher","first-page":"101986","DOI":"10.1016\/j.berh.2024.101986","volume":"38","author":"M Zajc Avramovic","year":"2024","unstructured":"Zajc Avramovic M, Avcin T (2024) Antiphospholipid syndrome in children. Best Pract Res Clin Rheumatol 38:101986. https:\/\/doi.org\/10.1016\/j.berh.2024.101986","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"9064_CR128","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1136\/annrheumdis-2011-201167","volume":"72","author":"A Mekinian","year":"2013","unstructured":"Mekinian A, Lachassinne E, Nicaise-Roland P, Carbillon L, Motta M, Vicaut E et al (2013) European registry of babies born to mothers with antiphospholipid syndrome. Ann Rheum Dis 72:217\u2013222. https:\/\/doi.org\/10.1136\/annrheumdis-2011-201167","journal-title":"Ann Rheum Dis"},{"key":"9064_CR129","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.chom.2019.05.003","volume":"26","author":"WE Ruff","year":"2019","unstructured":"Ruff WE, Dehner C, Kim WJ, Pagovich O, Aguiar CL, Yu AT et al (2019) Pathogenic Autoreactive T and B Cells Cross-React with Mimotopes Expressed by a Common Human Gut Commensal to Trigger Autoimmunity. Cell Host Microbe 26:100-113.e8. https:\/\/doi.org\/10.1016\/j.chom.2019.05.003","journal-title":"Cell Host Microbe"},{"key":"9064_CR130","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.autrev.2007.10.001","volume":"7","author":"D S\u00e8ne","year":"2008","unstructured":"S\u00e8ne D, Piette J-C, Cacoub P (2008) Antiphospholipid antibodies, antiphospholipid syndrome and infections. Autoimmun Rev 7:272\u2013277. https:\/\/doi.org\/10.1016\/j.autrev.2007.10.001","journal-title":"Autoimmun Rev"},{"key":"9064_CR131","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.autrev.2015.07.009","volume":"14","author":"M Garcia-Carrasco","year":"2015","unstructured":"Garcia-Carrasco M, Mendoza-Pinto C, Macias-Diaz S, Vazquez de Lara F, Etchegaray-Morales I, Galvez-Romero JL et al (2015) The role of infectious diseases in the catastrophic antiphospholipid syndrome. Autoimmun Rev 14:1066\u201371. https:\/\/doi.org\/10.1016\/j.autrev.2015.07.009","journal-title":"Autoimmun Rev"},{"key":"9064_CR132","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-023-07496-3","author":"L Depietri","year":"2023","unstructured":"Depietri L, Veropalumbo MR, Leone MC, Ghirarduzzi A (2023) Antiphospholipid Syndrome: State of the Art of Clinical Management. Cardiovasc Drugs Ther. https:\/\/doi.org\/10.1007\/s10557-023-07496-3","journal-title":"Cardiovasc Drugs Ther"},{"key":"9064_CR133","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.3390\/biomedicines11123117","volume":"11","author":"M Zlatkovi\u0107-\u0160venda","year":"2023","unstructured":"Zlatkovi\u0107-\u0160venda M, Ovuka M, Ogri\u010d M, \u010cu\u010dnik S, \u017digon P, Radiv\u010dev A et al (2023) Antiphospholipid Antibodies and Vascular Thrombosis in Patients with Severe Forms of COVID-19. Biomedicines 11:3117. https:\/\/doi.org\/10.3390\/biomedicines11123117","journal-title":"Biomedicines"},{"key":"9064_CR134","doi-asserted-by":"publisher","first-page":"101402","DOI":"10.1016\/j.beha.2022.101402","volume":"35","author":"A Butt","year":"2022","unstructured":"Butt A, Erkan D, Lee AI (2022) COVID-19 and antiphospholipid antibodies. Best Pract Res Clin Haematol 35:101402. https:\/\/doi.org\/10.1016\/j.beha.2022.101402","journal-title":"Best Pract Res Clin Haematol"},{"key":"9064_CR135","doi-asserted-by":"publisher","first-page":"103206","DOI":"10.1016\/j.autrev.2022.103206","volume":"21","author":"M Serrano","year":"2022","unstructured":"Serrano M, Espinosa G, Serrano A, Cervera R (2022) COVID-19 and the antiphospholipid syndrome. Autoimmun Rev 21:103206. https:\/\/doi.org\/10.1016\/j.autrev.2022.103206","journal-title":"Autoimmun Rev"},{"key":"9064_CR136","doi-asserted-by":"publisher","unstructured":"Gozzoli GI, Piovani E, Negri B, Mascherpa M, Orabona R, Zanardini C et al (2022) Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies. Front Immunol 13. https:\/\/doi.org\/10.3389\/fimmu.2022.953043","DOI":"10.3389\/fimmu.2022.953043"},{"key":"9064_CR137","doi-asserted-by":"publisher","first-page":"104442","DOI":"10.1016\/j.jri.2025.104442","volume":"168","author":"T Takeshita","year":"2025","unstructured":"Takeshita T, Nishimiya N, Hihara Y (2025) Does COVID-19 infection or COVID-19 mRNA vaccination induce antiphospholipid antibodies in women with recurrent pregnancy loss? J Reprod Immunol 168:104442. https:\/\/doi.org\/10.1016\/j.jri.2025.104442","journal-title":"J Reprod Immunol"},{"key":"9064_CR138","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.autrev.2014.12.010","volume":"14","author":"J Alijotas-Reig","year":"2015","unstructured":"Alijotas-Reig J, Ferrer-Oliveras R, Ruffatti A, Tincani A, Lefkou E, Bertero MAT et al (2015) The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases. Autoimmun Rev 14:387\u201395. https:\/\/doi.org\/10.1016\/j.autrev.2014.12.010","journal-title":"Autoimmun Rev"},{"key":"9064_CR139","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s12016-021-08915-9","volume":"63","author":"S Del Barrio-Longarela","year":"2022","unstructured":"Del Barrio-Longarela S, Mart\u00ednez-Taboada VM, Blanco-Olavarri P, Merino A, Riancho-Zarrabeitia L, Comins-Boo A et al (2022) Does Adjusted Global Antiphospholipid Syndrome Score (aGAPSS) Predict the Obstetric Outcome in Antiphospholipid Antibody Carriers? A Single-Center Study. Clin Rev Allergy Immunol 63:297\u2013310. https:\/\/doi.org\/10.1007\/s12016-021-08915-9","journal-title":"Clin Rev Allergy Immunol"},{"key":"9064_CR140","unstructured":"Recommendations | Hypertension in pregnancy: diagnosis and management | Guidance | NICE 2019. https:\/\/www.nice.org.uk\/guidance\/ng133\/chapter\/Recommendations#fetal-monitoring. Accessed 28 Apr 2025"},{"key":"9064_CR141","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11926-018-0718-4","volume":"20","author":"I Cavazzana","year":"2018","unstructured":"Cavazzana I, Andreoli L, Limper M, Franceschini F, Tincani A (2018) Update on Antiphospholipid Syndrome: Ten Topics in 2017. Curr Rheumatol Rep 20:15. https:\/\/doi.org\/10.1007\/s11926-018-0718-4","journal-title":"Curr Rheumatol Rep"},{"key":"9064_CR142","doi-asserted-by":"publisher","first-page":"e001044","DOI":"10.1136\/lupus-2023-001044","volume":"11","author":"L Luo","year":"2024","unstructured":"Luo L, Cai Q, Liu X, Hou Y, Li C (2024) Risk factors of first thrombosis in obstetric antiphospholipid syndrome. Lupus Sci Med 11:e001044. https:\/\/doi.org\/10.1136\/lupus-2023-001044","journal-title":"Lupus Sci Med"},{"key":"9064_CR143","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ajog.2004.09.029","volume":"192","author":"P Bose","year":"2005","unstructured":"Bose P, Black S, Kadyrov M, Weissenborn U, Neulen J, Regan L et al (2005) Heparin and aspirin attenuate placental apoptosis in vitro: Implications for early pregnancy failure. Am J Obstet Gynecol 192:23\u201330. https:\/\/doi.org\/10.1016\/j.ajog.2004.09.029","journal-title":"Am J Obstet Gynecol"},{"key":"9064_CR144","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1038\/nm1121","volume":"10","author":"G Girardi","year":"2004","unstructured":"Girardi G, Redecha P, Salmon JE (2004) Heparin prevents antiphospholipid antibody\u2013induced fetal loss by inhibiting complement activation. Nat Med 10:1222\u20131226. https:\/\/doi.org\/10.1038\/nm1121","journal-title":"Nat Med"},{"key":"9064_CR145","doi-asserted-by":"publisher","first-page":"108259","DOI":"10.1016\/j.clim.2019.108259","volume":"208","author":"M Wang","year":"2019","unstructured":"Wang M, Zhang P, Yu S, Zhou G, Lv J, Nallapothula D et al (2019) Heparin and aspirin combination therapy restores T-cell phenotype in pregnant patients with antiphospholipid syndrome-related recurrent pregnancy loss. Clin Immunol 208:108259. https:\/\/doi.org\/10.1016\/j.clim.2019.108259","journal-title":"Clin Immunol"},{"key":"9064_CR146","doi-asserted-by":"publisher","unstructured":"Hoxha A, Tormene D, Campello E, Simioni P (2022) Treatment of Refractory\/High-Risk Pregnancies With Antiphospholipid Syndrome: A Systematic Review of the Literature. Front Pharmacol 13. https:\/\/doi.org\/10.3389\/fphar.2022.849692.","DOI":"10.3389\/fphar.2022.849692"},{"key":"9064_CR147","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.autrev.2018.12.006","volume":"18","author":"J Alijotas-Reig","year":"2019","unstructured":"Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, S\u00e1ez-Comet L, Lefkou E, Mekinian A et al (2019) The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases. Autoimmun Rev 18:406\u2013414. https:\/\/doi.org\/10.1016\/j.autrev.2018.12.006","journal-title":"Autoimmun Rev"},{"key":"9064_CR148","doi-asserted-by":"publisher","first-page":"6157","DOI":"10.1080\/14767058.2021.1908992","volume":"35","author":"J Khizroeva","year":"2022","unstructured":"Khizroeva J, Bitsadze V, Tincani A, Makatsariya A, Arslanbekova M, Babaeva N et al (2022) Hydroxychloroquine in obstetric antiphospholipid syndrome: rationale and results of an observational study of refractory cases. J Matern-Fetal Neonatal Med 35:6157\u20136164. https:\/\/doi.org\/10.1080\/14767058.2021.1908992","journal-title":"J Matern-Fetal Neonatal Med"},{"key":"9064_CR149","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1177\/09612033221091401","volume":"31","author":"L Riancho-Zarrabeitia","year":"2022","unstructured":"Riancho-Zarrabeitia L, Lopez-Marin L, Cacho PM, L\u00f3pez-Hoyos M, del Barrio R, Haya A et al (2022) Treatment with low-dose prednisone in refractory obstetric antiphospholipid syndrome: A retrospective cohort study and meta-analysis. Lupus 31:808\u2013819. https:\/\/doi.org\/10.1177\/09612033221091401","journal-title":"Lupus"},{"key":"9064_CR150","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1600-0897.2008.00585.x","volume":"60","author":"EE Winger","year":"2008","unstructured":"Winger EE, Reed JL (2008) Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion. Am J Reprod Immunol 60:8\u201316. https:\/\/doi.org\/10.1111\/j.1600-0897.2008.00585.x","journal-title":"Am J Reprod Immunol"},{"key":"9064_CR151","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.semarthrit.2019.02.006","volume":"49","author":"J Alijotas-Reig","year":"2019","unstructured":"Alijotas-Reig J, Esteve-Valverde E, Llurba E, Gris JM (2019) Treatment of refractory poor aPL-related obstetric outcomes with TNF-alpha blockers: Maternal-fetal outcomes in a series of 18 cases. Semin Arthritis Rheum 49:314\u2013318. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.02.006","journal-title":"Semin Arthritis Rheum"},{"key":"9064_CR152","doi-asserted-by":"publisher","first-page":"109088","DOI":"10.1016\/j.thromres.2024.109088","volume":"241","author":"A-V Madenidou","year":"2024","unstructured":"Madenidou A-V, Kither H, Dyball S, Bruce IN, Tower C (2024) Added IMPACT: The first successful natural birth using certolizumab in obstetric APS. Thromb Res 241:109088. https:\/\/doi.org\/10.1016\/j.thromres.2024.109088","journal-title":"Thromb Res"},{"key":"9064_CR153","doi-asserted-by":"publisher","first-page":"e18419","DOI":"10.7717\/peerj.18419","volume":"12","author":"X Yuan","year":"2024","unstructured":"Yuan X, Zhang W, Wang T, Jiang P, Wang Z, Li C (2024) Use of intravenous immunoglobulin in antiphospholipid antibody positive patients with high risk of miscarriage: a systematic review and meta-analysis. PeerJ 12:e18419. https:\/\/doi.org\/10.7717\/peerj.18419","journal-title":"PeerJ"},{"key":"9064_CR154","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12016-016-8571-6","volume":"53","author":"A Ruffatti","year":"2017","unstructured":"Ruffatti A, Hoxha A, Favaro M, Tonello M, Colpo A, Cucchini U et al (2017) Additional Treatments for High-Risk Obstetric Antiphospholipid Syndrome: a Comprehensive Review. Clin Rev Allergy Immunol 53:28\u201339. https:\/\/doi.org\/10.1007\/s12016-016-8571-6","journal-title":"Clin Rev Allergy Immunol"},{"key":"9064_CR155","doi-asserted-by":"publisher","first-page":"102620","DOI":"10.1016\/j.autrev.2020.102620","volume":"19","author":"ML Urban","year":"2020","unstructured":"Urban ML, Bettiol A, Serena C, Comito C, Turrini I, Fruttuoso S et al (2020) Intravenous immunoglobulin for the secondary prevention of stillbirth in obstetric antiphospholipid syndrome: A case series and systematic review of literature. Autoimmun Rev 19:102620. https:\/\/doi.org\/10.1016\/j.autrev.2020.102620","journal-title":"Autoimmun Rev"},{"key":"9064_CR156","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jri.2016.03.004","volume":"115","author":"A Ruffatti","year":"2016","unstructured":"Ruffatti A, Favaro M, Hoxha A, Zambon A, Marson P, Del Ross T et al (2016) Apheresis and intravenous immunoglobulins used in addition to conventional therapy to treat high-risk pregnant antiphospholipid antibody syndrome patients. A prospective study. J Reprod Immunol 115:14\u201319. https:\/\/doi.org\/10.1016\/j.jri.2016.03.004","journal-title":"J Reprod Immunol"},{"key":"9064_CR157","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/mr\/road062","volume":"34","author":"K Kaneko","year":"2024","unstructured":"Kaneko K, Tsutsumi S, Fujita D, Sugiura-Ogasawara M, Mitsuda N, Matsubara K et al (2024) Intravenous immunoglobulin treatment for obstetric antiphospholipid syndrome refractory to conventional therapy: A single-arm, open-labelled multicentre clinical trial. Mod Rheumatol 34:515\u2013522. https:\/\/doi.org\/10.1093\/mr\/road062","journal-title":"Mod Rheumatol"},{"key":"9064_CR158","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1172\/JCI86957","volume":"126","author":"E Lefkou","year":"2016","unstructured":"Lefkou E, Mamopoulos A, Dagklis T, Vosnakis C, Rousso D, Girardi G (2016) Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy. J Clin Invest 126:2933\u20132940. https:\/\/doi.org\/10.1172\/JCI86957","journal-title":"J Clin Invest"},{"key":"9064_CR159","doi-asserted-by":"publisher","first-page":"114217","DOI":"10.1016\/j.bcp.2020.114217","volume":"182","author":"E Lefkou","year":"2020","unstructured":"Lefkou E, Varoudi K, Pombo J, Jurisic A, Jurisic Z, Contento G et al (2020) Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism. Biochem Pharmacol 182:114217. https:\/\/doi.org\/10.1016\/j.bcp.2020.114217","journal-title":"Biochem Pharmacol"},{"key":"9064_CR160","doi-asserted-by":"publisher","first-page":"e12584","DOI":"10.1097\/MD.0000000000012584","volume":"97","author":"P Rovere-Querini","year":"2018","unstructured":"Rovere-Querini P, Canti V, Erra R, Bianchi E, Slaviero G, D\u2019Angelo A et al (2018) Eculizumab in a pregnant patient with laboratory onset of catastrophic antiphospholipid syndrome: A case report. Medicine (Baltimore) 97:e12584. https:\/\/doi.org\/10.1097\/MD.0000000000012584","journal-title":"Medicine (Baltimore)"},{"key":"9064_CR161","doi-asserted-by":"publisher","first-page":"e6338","DOI":"10.1097\/MD.0000000000006338","volume":"96","author":"A Gustavsen","year":"2017","unstructured":"Gustavsen A, Skattum L, Bergseth G, Lorentzen B, Floisand Y, Bosnes V et al (2017) Effect on mother and child of eculizumab given before caesarean section in a patient with severe antiphospholipid syndrome: A case report. Medicine (Baltimore) 96:e6338. https:\/\/doi.org\/10.1097\/MD.0000000000006338","journal-title":"Medicine (Baltimore)"},{"key":"9064_CR162","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/24725625.2019.1648633","volume":"4","author":"M Nagata","year":"2020","unstructured":"Nagata M, Kaneko K, Kohno C, Mishima S, Okazaki Y, Murashima A (2020) A case of successful pregnancy following multidrug treatment including rituximab and intravenous immunoglobulin for primary antiphospholipid antibody syndrome refractory to conventional treatment. Mod Rheumatol Case Rep 4:47\u201350. https:\/\/doi.org\/10.1080\/24725625.2019.1648633","journal-title":"Mod Rheumatol Case Rep"},{"key":"9064_CR163","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s11845-008-0265-5","volume":"178","author":"CT Ng","year":"2009","unstructured":"Ng CT, O\u2019Neil M, Walsh D, Walsh T, Veale DJ (2009) Successful pregnancy after rituximab in a women with recurrent in vitro fertilisation failures and anti-phospholipid antibody positive. Ir J Med Sci 178:531\u2013533. https:\/\/doi.org\/10.1007\/s11845-008-0265-5","journal-title":"Ir J Med Sci"},{"key":"9064_CR164","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.autrev.2015.01.012","volume":"14","author":"A Mekinian","year":"2015","unstructured":"Mekinian A, Lazzaroni MG, Kuzenko A, Alijotas-Reig J, Ruffatti A, Levy P et al (2015) The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: Data from a European multicenter retrospective study. Autoimmun Rev 14:498\u2013502. https:\/\/doi.org\/10.1016\/j.autrev.2015.01.012","journal-title":"Autoimmun Rev"},{"key":"9064_CR165","doi-asserted-by":"publisher","first-page":"668","DOI":"10.3390\/ijms25010668","volume":"25","author":"V Bitsadze","year":"2024","unstructured":"Bitsadze V, Yakubova F, Khizroeva J, Lazarchuk A, Salnikova P, Vorobev A et al (2024) Catastrophic Antiphospholipid Syndrome. Int J Mol Sci 25:668. https:\/\/doi.org\/10.3390\/ijms25010668","journal-title":"Int J Mol Sci"},{"key":"9064_CR166","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s11883-022-01039-1","volume":"24","author":"A Pham","year":"2022","unstructured":"Pham A, Polic A, Nguyen L, Thompson JL (2022) Statins in Pregnancy: Can We Justify Early Treatment of Reproductive Aged Women? Curr Atheroscler Rep 24:663\u2013670. https:\/\/doi.org\/10.1007\/s11883-022-01039-1","journal-title":"Curr Atheroscler Rep"},{"key":"9064_CR167","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1161\/CIRCULATIONAHA.121.053963","volume":"144","author":"M D\u00f6bert","year":"2021","unstructured":"D\u00f6bert M, Varouxaki AN, Mu AC, Syngelaki A, Ciobanu A, Akolekar R et al (2021) Pravastatin Versus Placebo in Pregnancies at High Risk of Term Preeclampsia. Circulation 144:670\u2013679. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.053963","journal-title":"Circulation"},{"key":"9064_CR168","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1177\/1352458521998937","volume":"27","author":"C Hollen","year":"2021","unstructured":"Hollen C, Rice J, Park M, Yadav V (2021) Rituximab for treatment of refractory multiple sclerosis relapses during pregnancy. Mult Scler Houndmills Basingstoke Engl 27:1620\u20131623. https:\/\/doi.org\/10.1177\/1352458521998937","journal-title":"Mult Scler Houndmills Basingstoke Engl"},{"key":"9064_CR169","doi-asserted-by":"publisher","first-page":"e038","DOI":"10.1097\/JW9.0000000000000038","volume":"8","author":"A Dehghanimahmoudabadi","year":"2022","unstructured":"Dehghanimahmoudabadi A, Kianfar N, Akhdar M, Dasdar S, Balighi K, Mahmoudi H et al (2022) Pregnancy outcomes in women with pemphigus exposed to rituximab before or during pregnancy. Int J Womens Dermatol 8:e038. https:\/\/doi.org\/10.1097\/JW9.0000000000000038","journal-title":"Int J Womens Dermatol"},{"key":"9064_CR170","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1080\/10428194.2022.2100368","volume":"63","author":"S On","year":"2022","unstructured":"On S, Chang A (2022) Treatment of lymphoma with rituximab and chemotherapy during pregnancy. Leuk Lymphoma 63:2897\u20132904. https:\/\/doi.org\/10.1080\/10428194.2022.2100368","journal-title":"Leuk Lymphoma"},{"key":"9064_CR171","doi-asserted-by":"publisher","unstructured":"Pleguezuelo DE, D\u00edaz-Sim\u00f3n R, Cabrera-Marante O, Lalueza A, Paz-Artal E, Lumbreras C et al (2021) Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid Syndrome. Front Immunol 12. https:\/\/doi.org\/10.3389\/fimmu.2021.667515","DOI":"10.3389\/fimmu.2021.667515"},{"key":"9064_CR172","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1093\/rheumatology\/kex067","volume":"56","author":"V Reddy","year":"2017","unstructured":"Reddy V, Klein C, Isenberg DA, Glennie MJ, Cambridge G, Cragg MS et al (2017) Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples. Rheumatology 56:1227\u20131237. https:\/\/doi.org\/10.1093\/rheumatology\/kex067","journal-title":"Rheumatology"},{"key":"9064_CR173","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jtha.2024.09.024","volume":"23","author":"E Friedberg","year":"2025","unstructured":"Friedberg E, Wohlfarth P, Schiefer AI, Skrabs C, Pickl WF, Worel N et al (2025) Disappearance of antiphospholipid antibodies after anti-CD19 chimeric antigen receptor T-cell therapy of B-cell lymphoma in a patient with systemic lupus erythematosus and antiphospholipid syndrome. J Thromb Haemost 23:262\u2013266. https:\/\/doi.org\/10.1016\/j.jtha.2024.09.024","journal-title":"J Thromb Haemost"},{"key":"9064_CR174","doi-asserted-by":"publisher","first-page":"605.e1","DOI":"10.1016\/j.jtct.2022.06.002","volume":"28","author":"JA Ligon","year":"2022","unstructured":"Ligon JA, Fry A, Maher JY, Foley T, Silbert S, Yates B et al (2022) Fertility and CAR T-cells: Current practice and future directions. Transplant Cell Ther 28:605.e1-605.e8. https:\/\/doi.org\/10.1016\/j.jtct.2022.06.002","journal-title":"Transplant Cell Ther"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-025-09064-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-025-09064-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-025-09064-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T14:27:34Z","timestamp":1749392854000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-025-09064-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,8]]},"references-count":174,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9064"],"URL":"https:\/\/doi.org\/10.1007\/s12016-025-09064-z","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,8]]},"assertion":[{"value":"28 May 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"55"}}